Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer
Palliativversorgung als Bestandteil von High-Value- und kostensparender Versorgung während der Hospitalisierung bei metastasiertem Krebs
JCO Oncology Practice · 2025-02 · 21 (2) · 252-260
DOI: 10.1200/op.23.00576 ↗Auf einen Blick
Bei 397.691 Hospitalisierungen war stationäre Palliativversorgung mit niedrigeren Krankenhauskosten verbunden. Die Kostenreduktion blieb unabhängig von Alter und invasiven Maßnahmen bestehen.
Fragestellung
Ist stationäre Palliativversorgung bei Hospitalisierung wegen metastasiertem Krebs mit geringeren Krankenhauskosten verbunden?
Methode
Analyse von Hospitalisierungen von Patient:innen ab 18 Jahren mit primärer Diagnose metastasierter Krebs im National Inpatient Sample 2010–2019; multivariable Mixed-Effects-Modelle.
Ergebnisse
Unter stationärer Palliativversorgung waren die Abrechnungen niedriger (OR 0,62; 95 %-KI 0,61–0,64) und die Kosten niedriger (OR 0,59; 95 %-KI 0,58–0,61). Die Kosten pro Hospitalisierung sanken um 1.310 USD (−13,6 %).
Schlussfolgerung der Autor:innen
Stationäre Palliativversorgung ist mit geringeren Krankenhauskosten bei metastasiertem Krebs verbunden, unabhängig von Alter und aggressiven Interventionen.
Kernaussagen
- 397.691 Hospitalisierungen wurden analysiert
- Palliativversorgung senkte Abrechnungen und Kosten
- Kostenreduktion: 1.310 USD pro Hospitalisierung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2025-02. Verfasst von Sifan Lu und 15 weiteren Autor:innen. Beteiligte Einrichtung: SUNY Downstate Health Sciences University, Brooklyn, NY. Hauptthemen laut MEDLINE: Palliative Care, Hospitalization, Neoplasms, Cost Savings. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: NIA NIH HHS.
Themen: Palliativpflege
Abstract (Originalsprache)
PURPOSE Randomized controlled trials have demonstrated that palliative care (PC) can improve quality of life and survival for outpatients with advanced cancer, but there are limited population-based data on the value of inpatient PC. We assessed PC as a component of high-value care among a nationally representative sample of inpatients with metastatic cancer and identified hospitalization characteristics significantly associated with high costs. METHODS Hospitalizations of patients 18 years and older with a primary diagnosis of metastatic cancer from the National Inpatient Sample from 2010 to 2019 were analyzed. We used multivariable mixed-effects logistic regression to assess medical services, patient demographics, and hospital characteristics associated with higher charges billed to insurance and hospital costs. Generalized linear mixed-effects models were used to determine cost savings associated with provision of PC. RESULTS Among 397,691 hospitalizations from 2010 to 2019, the median charge per admission increased by 24.9%, from $44,904 in US dollars (USD) to $56,098 USD, whereas the median hospital cost remained stable at $14,300 USD. Receipt of inpatient PC was associated with significantly lower charges (odds ratio [OR], 0.62 [95% CI, 0.61 to 0.64]; P < .001) and costs (OR, 0.59 [95% CI, 0.58 to 0.61]; P < .001). Factors associated with high charges were receipt of invasive medical ventilation ( P < .001) or systemic therapy ( P < .001), Hispanic patients ( P < .001), young age (18-49 years, P < .001), and for-profit hospitals ( P < .001). PC provision was associated with a $1,310 USD (–13.6%, P < .001) reduction in costs per hospitalization compared with no PC, independent of the receipt of invasive care and age. CONCLUSION Inpatient PC is associated with reduced hospital costs for patients with metastatic cancer, irrespective of age and receipt of aggressive interventions. Integration of inpatient PC may de-escalate costs incurred through low-value inpatient interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- SUNY Downstate Health Sciences University, Brooklyn, NY.
- Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, Canada.
- Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- Department of Radiation Oncology and the Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- Department of Otolaryngology Head and Neck Surgery, University Health Network, Toronto, ON, Canada.
ORCID-Profile: Sifan Lu, Breffni Hannon, Camilla Zimmermann, Kavita V Dharmarajan, John R De Almeida, Christopher M K L Yao, Erin F Gillespie, Fumiko Chino, Divya Yerramilli, Ethan Goonaratne, Sara Mheid, Chiaojung Jillian Tsai
Förderung
- NIA NIH HHS
Zitieren
APA
Lu, S., Rakovitch, E., Hannon, B., Zimmermann, C., Dharmarajan, K. V., Yan, M., De Almeida, J. R., Yao, C. M. K. L., Gillespie, E. F., Chino, F., Yerramilli, D., Goonaratne, E., Abdel-Rahman, F., Othman, H., Mheid, S., & Tsai, C. J. (2025). Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer. JCO Oncology Practice, 21(2), 252-260. https://doi.org/10.1200/op.23.00576
Vancouver
Lu S, Rakovitch E, Hannon B, Zimmermann C, Dharmarajan KV, Yan M, et al. Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer. JCO Oncology Practice. 2025;21(2):252-260. doi:10.1200/op.23.00576
BibTeX
@article{Lu2025,
author = {Lu, Sifan and Rakovitch, Eileen and Hannon, Breffni and Zimmermann, Camilla and Dharmarajan, Kavita V and Yan, Michael and De Almeida, John R and Yao, Christopher M K L and Gillespie, Erin F and Chino, Fumiko and Yerramilli, Divya and Goonaratne, Ethan and Abdel-Rahman, Fadwa and Othman, Hiba and Mheid, Sara and Tsai, Chiaojung Jillian},
title = {Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer},
journal = {JCO Oncology Practice},
year = {2025},
volume = {21},
number = {2},
pages = {252--260},
doi = {10.1200/op.23.00576}
}
EUVIMED